Manufacturing of clinical supplies up to commercial quantities of APIs, formulations, and complete products for inhalation and nasal dosage forms, including metered dose inhalers (MDIs), dry powder inhalers (DPIs), inhalation solutions, and nasal sprays
Lonza provides integrated DPI (dry powder inhaler) services to advance molecules, drawing on 25 years of experience in particle engineering, formulation design, and encapsulation techniques. Our premier particle engineering services, utilizing both micronization and spray drying techniques, are tailored to your molecule, target product profile and delivery device. Dedicated DPI formulation and manufacturing teams ensure that development timelines are met while minimizing program risk and complexity.
At Kindeva, we Manufacture More Tomorrows™ for patients worldwide. With best-in-class facilities and comprehensive CDMO services, we offer more than manufacturing—we deliver strategic value. Our global network of 10 manufacturing and R&D sites offer exceptional integrated knowledge and capabilities, including Annex 1-compliant state-of-the-art aseptic fill finish capacity and next-generation sustainable inhalation propellant technology. By combining expertise in injectable, pulmonary, nasal, and dermal drug delivery, we help meet the demands of today and deliver the possibilities of tomorrow.
Expertise and proven success in pulmonary & nasal delivery: Catalent is your preferred CDMO for pulmonary and nasal delivery, with clinical to commercial-scale development and manufacturing capabilities for dry powder inhalers, as well as liquid and powder unit-dose, bi-dose and multi-dose nasal sprays. With over 30 years of inhalation product experience and state-of-the-art facilities in Boston, MA and Morrisville, NC Catalent can handle the most complex projects and help bring your inhaled therapy to market, faster.
At LTS, we CARE for patients, partners, employees, and communities, we CREATE innovative drug delivery solutions, and we DELIVER high-quality products worldwide. As a global CDMO, we provide end-to-end development and manufacturing for pharma and biotech companies. Our technologies include transdermal patches, oral thin films, nasal and sterile drug delivery products, wearable devices, and microneedle patches. With 40+ commercial products and 50+ active programs, we advance small molecules, biologics, and vaccines. Operating from five sites in the US, Germany, and Israel, plus a China office, LTS combines expertise and patient-centric innovation to power the future of drug delivery.
Would you like to list your company in this section or upgrade your existing listing? For information about supplier listing options, click here.
